ArticleBrain communications2026
Fetal brain volumes and brain gyrification index associated with opioid exposure.
Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Opioid use during pregnancy continues to be a significant public health challenge, with antenatal opioid exposure suggesting adverse infant and child health outcomes. Early identification of risk of future neurodevelopmental disorders could help improve long-term health outcomes in these children. In this study, we assess whether prenatal opioid exposure is associated with early alterations in human fetal brain development identifiable on fetal MRI. This was a prospective, institutional review board approved, multicenter study that recruited pregnant women on medication-assisted treatment (MAT) for opioid use disorder (OUD) and a control cohort of non-OUD pregnant women. Fetal brain MRI was performed in the second or third trimester of gestation. Semiautomated pipelines were used to create super-resolution 3D isotropic anatomic brain magnetic resonance images from 2D fetal brain images and segmented into different tissue types. Fetal brain gyrification indices were also calculated. Differences between fetuses with opioid exposure and control fetuses were assessed. There were 63 fetuses in this study-31 with opioid exposure and 32 without opioid exposure (controls). Fetuses with opioid exposure had significantly smaller fetal brain total volumes, fetal brain white matter volume, and significantly lower fetal brain gyrification index compared to control fetuses. In opioid exposed fetuses, fetal brain volumetric and surface-based metrics did not correlate with severity of neonatal opioid withdrawal syndrome (NOWS) requiring longer hospitalization or postnatal opioid medication treatment. Additional and larger prospective studies are needed to understand how fetal brain development may be associated with short- and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.